** India gets third COVID-19 vaccine as DCGI approves restricted emergency use of Sputnik V

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

The DCGI had in January given the emergency use authorisation for two COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca manufactured by Serum Institute of India in Pune.

Leave a Reply

Your email address will not be published. Required fields are marked *